Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%

Page 9 of 10

Page 9 of 10 – SEC Filing
CUSIP
No. M46135105
13G Page
9 of 9 Pages

SIGNATURE

After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: October 11, 2016

GREAT POINT PARTNERS, LLC
By: /s/ Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D.,
as senior managing member
/s/ Dr. Jeffrey R. Jay, M.D.
DR. JEFFREY R. JAY, M.D.
/s/ Mr. David Kroin
MR. DAVID KROIN

Follow Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Page 9 of 10